NCT00024154View on ClinicalTrials.gov

Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

132

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

July 31, 2007

Conditions
Male Breast CancerRecurrent Breast CancerStage IV Breast Cancer
Interventions
BIOLOGICAL

trastuzumab

Given IV

DRUG

gefitinib

Given orally

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

02215

Eastern Cooperative Oncology Group, Boston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00024154 - Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter